BamSEC and AlphaSense Join Forces
Learn More

Pacific Biosciences of California Inc.

NASDAQ: PACB    
Share price (12/20/24): $1.97    
Market cap (12/20/24): $540 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K/A 10 pages Separation Agreement and Release
12/34/56
EX-10.1
from 8-K 8 pages Side Letter Agreement
12/34/56
EX-10.1
from 8-K 7 pages November 7, 2024 A
12/34/56
EX-10.3
from 8-K 24 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Global Restricted Stock Unit Agreement Notice of Restricted Stock Unit Grant
12/34/56
EX-10.2
from 8-K 22 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Global Stock Option Agreement Notice of Stock Option Grant
12/34/56
EX-10.1
from 8-K 20 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan
12/34/56
EX-10.28
from 10-K 6 pages Material contract
12/34/56
EX-10.1
from 8-K 5 pages June 23, 2023 A
12/34/56
EX-10.27
from 10-K 5 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Performance-Based Restricted Stock Unit Agreement Notice of Restricted Stock Unit Grant
12/34/56
EX-10.1
from 10-Q 17 pages Background
12/34/56
EX-10.3
from 8-K 17 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Global Restricted Stock Unit Agreement Notice of Restricted Stock Unit Grant
12/34/56
EX-10.2
from 8-K 20 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Global Stock Option Agreement Notice of Stock Option Grant
12/34/56
EX-10.1
from 8-K 17 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan
12/34/56
EX-10.2
from 10-Q 13 pages Pacific Biosciences of California, Inc. Change in Control and Severance Agreement
12/34/56
EX-10.1
from 8-K 60 pages Pacific Biosciences of California, Inc. 2020 Inducement Equity Incentive Plan
12/34/56
EX-10.4
from 10-Q 57 pages Omniome Equity Incentive Plan of Pacific Biosciences of California, Inc
12/34/56
EX-10.6
from 10-Q 2 pages Certain Confidential Information Contained in This Document, Marked by Brackets ([***]), Has Been Omitted Because the Information (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.2
from 10-Q 3 pages  March 23, 2021   Michele Farmer   Dear Michele,  on Behalf of Pacific Biosciences of California, Inc. (The “Company”), I Am Pleased to Offer You a Position at the Company as Chief Accounting Officer. You Will Be Reporting to Susan Kim.  You Will Receive a Salary of $295,000 Annually, Paid Twice Monthly According to the Company’s Payroll Schedule. 
12/34/56
EX-10.3
from 8-K 26 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 37 pages Securities Purchase Agreement Recitals
12/34/56